States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors
Fluid bed processes: drying, granulating, and coating in just one product container
Highly effective preservation solutions ensuring the safety and protection of personal care products
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Minister was briefed on the nationwide dengue situation
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Take proper precautions and seek timely treatment!
Subscribe To Our Newsletter & Stay Updated
